Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIronwood Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $0.24 | $0.26 | $0.25 |
| Q2 2026 | 1 | $0.36 | $0.39 | $0.38 |
| Q3 2026 | 1 | $0.34 | $0.37 | $0.36 |
| Q4 2026 | 1 | $0.33 | $0.36 | $0.34 |
| Q1 2027 | 1 | $0.25 | $0.27 | $0.26 |
| Q2 2027 | 1 | $0.30 | $0.32 | $0.31 |
| Q3 2027 | 1 | $0.32 | $0.35 | $0.33 |
| Q4 2027 | 1 | $0.34 | $0.37 | $0.35 |
| Q1 2028 | 1 | $0.29 | $0.31 | $0.30 |
| Q2 2028 | 1 | $0.34 | $0.37 | $0.35 |
| Q3 2028 | 1 | $0.36 | $0.39 | $0.37 |
| Q4 2028 | 1 | $0.38 | $0.41 | $0.39 |
Ironwood Pharmaceuticals Inc Earnings Date And Information
Ironwood Pharmaceuticals Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $0.24 earnings per share for the quarter, missing analysts' consensus estimates of $0.2467 by $0.0067. The company had revenue of 106.51 M for the quarter and had revenue of 296.15 M for the year. Ironwood Pharmaceuticals Inc has generated $0 earnings per share over the last year ($0.15 diluted earnings per share) and currently has a price-to-earnings ratio of 3.98. Ironwood Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Ironwood Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | $0.25 | $0.25 | 0 | $92.11 M | $106.51 M |
| 02/26/2026 | Q4 2025 | N/A | -$0.01 | N/A | $50.92 M | $47.71 M |
| 11/10/2025 | Q3 2025 | $0.09 | $0.25 | 0.16 | $74.71 M | $122.06 M |
| 08/11/2025 | Q2 2025 | N/A | $0.15 | N/A | $60.78 M | $85.24 M |
| 05/12/2025 | Q1 2025 | N/A | -$0.23 | N/A | $45.90 M | $41.14 M |
| 03/31/2025 | Q4 2024 | N/A | $0.01 | N/A | $93.77 M | $90.55 M |
| 11/07/2024 | Q3 2024 | $0.08 | $0.02 | -0.06 | $91.22 M | $91.59 M |
| 08/08/2024 | Q2 2024 | $0.15 | -$0.01 | -0.16 | $107.10 M | $94.40 M |
| 05/09/2024 | Q1 2024 | $0.18 | -$0.03 | -0.21 | $105.75 M | $74.88 M |
| 02/16/2024 | Q4 2023 | N/A | -$0.01 | N/A | N/A | $117.55 M |
| 11/09/2023 | Q3 2023 | $0.16 | $0.10 | -0.06 | N/A | $113.74 M |
| 08/09/2023 | Q2 2023 | N/A | -$6.84 | N/A | N/A | $107.38 M |
| 05/04/2023 | Q1 2023 | $0.24 | $0.30 | 0.06 | N/A | $104.06 M |
| 02/16/2023 | Q4 2022 | $0.27 | $0.32 | 0.05 | N/A | $107.20 M |
| 11/03/2022 | Q3 2022 | $0.27 | $0.28 | 0.01 | N/A | $108.64 M |
| 08/04/2022 | Q2 2022 | $0.30 | $0.24 | -0.06 | N/A | $97.23 M |
| 05/05/2022 | Q1 2022 | $0.26 | $0.21 | -0.05 | N/A | $97.53 M |
| 02/17/2022 | Q4 2021 | N/A | $0.25 | N/A | N/A | $117.13 M |
| 11/04/2021 | Q3 2021 | $0.31 | $0.34 | 0.03 | N/A | $103.75 M |
| 08/05/2021 | Q2 2021 | $0.23 | $2.42 | 2.19 | N/A | $104.03 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ironwood Pharmaceuticals Inc Earnings: FAQ's
The conference call for Ironwood Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Ironwood Pharmaceuticals Inc's latest earnings report can be read online.
Ironwood Pharmaceuticals Inc (:IRWD) has a recorded annual revenue of $296.15 M.
Ironwood Pharmaceuticals Inc (:IRWD) has a recorded net income of $24.02 M.Ironwood Pharmaceuticals Inc has generated $0.15 earnings per share over the last four quarters.
Ironwood Pharmaceuticals Inc (:IRWD) has a price-to-earnings ratio of 3.98 and price/earnings-to-growth ratio is 0.